Immune cell impact of three differently coated lipid nanocapsules: pluronic, chitosan and polyethylene glycol
Open Access
- 5 January 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 18423
Abstract
Lipid nanocapsules (NCs) represent promising tools in clinical practice for diagnosis and therapy applications. However, the NC appropriate functionalization is essential to guarantee high biocompatibility and molecule loading ability. In any medical application, the immune system-impact of differently functionalized NCs still remains to be fully understood. A comprehensive study on the action exerted on human peripheral blood mononuclear cells (PBMCs) and major immune subpopulations by three different NC coatings: pluronic, chitosan and polyethylene glycol-polylactic acid (PEG) is reported. After a deep particle characterization, the uptake was assessed by flow-cytometry and confocal microscopy, focusing then on apoptosis, necrosis and proliferation impact in T cells and monocytes. Cell functionality by cell diameter variations, different activation marker analysis and cytokine assays were performed. We demonstrated that the NCs impact on the immune cell response is strongly correlated to their coating. Pluronic-NCs were able to induce immunomodulation of innate immunity inducing monocyte activations. Immunomodulation was observed in monocytes and T lymphocytes treated with Chitosan-NCs. Conversely, PEG-NCs were completely inert. These findings are of particular value towards a pre-selection of specific NC coatings depending on biomedical purposes for pre-clinical investigations;i.e.the immune-specific action of particular NC coating can be excellent for immunotherapy applications.Keywords
This publication has 82 references indexed in Scilit:
- Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer VaccineJournal of Immunology Research, 2013
- Functionalized multiwalled carbon nanotubes as ultrasound contrast agentsProceedings of the National Academy of Sciences, 2012
- Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection deliveryInternational Journal of Nanomedicine, 2012
- Novel Drug Delivery System Based on Docetaxel-Loaded Nanocapsules as a Therapeutic Strategy Against Breast Cancer CellsInternational Journal of Molecular Sciences, 2012
- Characterization of Different Functionalized Lipidic Nanocapsules as Potential Drug CarriersInternational Journal of Molecular Sciences, 2012
- Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulationInternational Journal of Nanomedicine, 2012
- SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discoveryJournal of Translational Medicine, 2011
- Nanomedicinal Strategies to Treat Multidrug-Resistant Tumors: Current ProgressNanomedicine, 2010
- Minireview: Nanoparticles and the Immune SystemEndocrinology, 2010
- An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytesBlood, 2010